Belite Bio
Stock Forecast, Prediction & Price Target
Belite Bio Financial Estimates
Belite Bio Revenue Estimates
Belite Bio EBITDA Estimates
Belite Bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $10M Low: $10M High: $10M avg. 0% | Avg: $32.46M Low: $32.46M High: $32.46M avg. 224.66% | Avg: $92.15M Low: $92.15M High: $92.15M avg. 183.84% | Avg: $198.41M Low: $198.41M High: $198.41M avg. 115.31% |
Net Income
% change YoY
| $-9.79M N/A | $-12.47M -27.39% | $-31.63M -153.56% | Avg: $-25.63M Low: $-34.30M High: $2.65M avg. 18.97% | Avg: $-19.45M Low: $-39.89M High: $-1.86M avg. 24.08% | Avg: $10.99M Low: $10.99M High: $10.99M avg. 156.49% | Avg: $72.15M Low: $72.15M High: $72.15M avg. 556.45% |
EBITDA
% change YoY
| $-9.63M N/A | $-12.43M -29.03% | $-31.52M -153.57% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$0.41 N/A | -$0.62 -51.21% | -$1.19 -91.93% | Avg: -$0.84 Low: -$1.29 High: $0.1 avg. 29.07% | Avg: -$0.64 Low: -$1.5 High: -$0.07 avg. 24.17% | Avg: $0.41 Low: $0.41 High: $0.41 avg. 164.58% | Avg: $2.71 Low: $2.71 High: $2.71 avg. 556.45% |
Operating Expenses
% change YoY
| $9.79M N/A | $12.82M 30.86% | $31.66M 147.00% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Belite Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 189.00% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -34.30M, average is -25.63M and high is 2.65M.
What is Belite Bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 130.95% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $10M, average is $10M and high is $10M.
What is Belite Bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 193.57% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.29, average is -$0.84 and high is $0.1.